Lee Rosebush Writes Article Examining DEA Drug Quota System

Articles / August 13, 2018

Partner Lee Rosebush authored an article published in the August/September 2018 issue of Update, the magazine of the Food and Drug Law Institute. The article, “The DEA Quota System,” examines the required aggregate production quotas for controlled substances, established to prevent diversion and abuse of these drugs while ensuring an adequate supply. Rosebush, and his co-author, BakerHostetler summer associate Marc Wagner, write:

“The DEA quota system affects patients, medical practitioners, scientists, and industry alike. Understanding how the DEA quota system works will help those affected by it, especially bulk active pharmaceutical ingredients (API) manufacturers, drug manufacturers, packagers, repackagers, labelers, relabelers, and 503B Outsourcing Facilities. Likewise, with increased attention on the opioid crisis, the DEA quota system is one tool that could be used to help curb the opioid crisis.”

Read the article.